ArticleAddiction (Abingdon, England)2026
Marketing features of derived intoxicating cannabinoid product brands on Instagram: A content analysis.
Article in Addiction (Abingdon, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
BACKGROUND AND
aimsUse of derived intoxicating cannabinoid products (DICPs) has grown in the United States (US), as have associated poisonings, emergency department visits and psychotic episodes. Brand marketing on social media, a largely underregulated marketing channel, may be contributing to this growth. To inform prevention efforts, this study characterized marketing features used by leading DICP brands on Instagram.
designQualitative content analysis. SETTING AND CASES: A total of 837 Instagram posts published by nine leading DICP brands' (CannaAid, Cycling Frog, Delta Extrax, Elyxr, Fly Urb, Hometown Hero, Koi CBD, Mood and Official Canna River) accounts between February 2024 and February 2025. MEASUREMENTS: The research team developed a codebook of marketing features using both inductive and deductive methods, and two trained coders analyzed the content of the posts (n = 837). Frequencies were calculated for each marketing feature, and Chi-squared tests were used to examine associations of marketing feature themes by brand and product type.
findingsSocial media posts featured product descriptors and imagery (product theme; 75.3%), recreational effects and enjoyment appeals (recreational theme; 52.0%), youth-oriented imagery and cultural cues (youth theme; 49.6%), brand and value positioning (brand theme; 35.7%), health and therapeutic benefit claims (health theme; 10.2%) and health and age warnings (warning theme; 2.5%). Theme presence differed statistically significantly by brand (Ps< 0.001). Cycling Frog used product (93.4%), recreational (83.7%) and brand (50.6%) themes most frequently. Mood (64.4%) and Delta Extrax (60.1%) used the youth theme most frequently, while Hometown Hero (23.7%) and Koi CBD (17.7%) used the health theme most frequently. Themes also varied statistically significantly by product type (Ps< 0.05). Beverages were the product type most commonly marketed with product (97.4%), recreational (84.3%), youth (56.9%) and brand (40.5%) themes. Edibles (60.8%) and pre-rolls/blunts (52.9%) were frequently marketed with the recreational theme, while cartridges/vapes (53.5%) and edibles (49.2%) were frequently marketed with the youth theme.
conclusionsBetween February 2024 and February 2025, Instagram posts from leading brands of derived intoxicating cannabinoid products frequently emphasized product, recreational and youth-oriented themes, while age restrictions and health warning messages were less common. Marketing content varied by brand and product type, with beverages particularly likely to feature recreational, lifestyle and youth-appealing elements.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.